Matches in SemOpenAlex for { <https://semopenalex.org/work/W180986823> ?p ?o ?g. }
- W180986823 endingPage "53" @default.
- W180986823 startingPage "49" @default.
- W180986823 abstract "Researchers are constantly seeking ways to improve existing drugs, drug mechanisms of activity, find new indications for old drugs or to develop new drugs to treat urological diseases and conditions. In Canada, tadalafil in a 5 mg daily dosage (old drug), and a new drug, silodosin, have recently become available to treat patients who have benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS). In clinical studies, silodosin has shown promise as a treatment for ureteral stones, whereas it has shown conflicting results as a potential treatment for prostatitis. Two new therapies have emerged for treating overactive bladder (OAB): Mirabegron (not yet available in Canada) and fesoterodine (newly introduced in the marketplace). New therapies--denosumab (to prevent skeletal events) and abiraterone acetate and enzalutamide--were recently approved to treat certain patients with advanced prostate cancer. With the advent of new therapies to treat urological diseases, in many cases, primary management of the patient is often shifted from the urologist to the family physician, and sometimes moved from the oncologist to the urologist." @default.
- W180986823 created "2016-06-24" @default.
- W180986823 creator A5055025886 @default.
- W180986823 creator A5073537684 @default.
- W180986823 date "2012-10-01" @default.
- W180986823 modified "2023-10-14" @default.
- W180986823 title "Emerging therapies: what's new is old and what's old is new." @default.
- W180986823 cites W148823061 @default.
- W180986823 cites W1590209850 @default.
- W180986823 cites W1597281040 @default.
- W180986823 cites W174598520 @default.
- W180986823 cites W1995256786 @default.
- W180986823 cites W2013459993 @default.
- W180986823 cites W2037558979 @default.
- W180986823 cites W2044628637 @default.
- W180986823 cites W2056030667 @default.
- W180986823 cites W2068640487 @default.
- W180986823 cites W2104923745 @default.
- W180986823 cites W2110534364 @default.
- W180986823 cites W2139860898 @default.
- W180986823 cites W2148643283 @default.
- W180986823 cites W2169016904 @default.
- W180986823 cites W2171512008 @default.
- W180986823 cites W2310656226 @default.
- W180986823 cites W2400264479 @default.
- W180986823 cites W2408246273 @default.
- W180986823 cites W2413008035 @default.
- W180986823 cites W2414822843 @default.
- W180986823 cites W2418067796 @default.
- W180986823 cites W44559748 @default.
- W180986823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23089348" @default.
- W180986823 hasPublicationYear "2012" @default.
- W180986823 type Work @default.
- W180986823 sameAs 180986823 @default.
- W180986823 citedByCount "0" @default.
- W180986823 crossrefType "journal-article" @default.
- W180986823 hasAuthorship W180986823A5055025886 @default.
- W180986823 hasAuthorship W180986823A5073537684 @default.
- W180986823 hasConcept C121608353 @default.
- W180986823 hasConcept C126322002 @default.
- W180986823 hasConcept C126894567 @default.
- W180986823 hasConcept C142724271 @default.
- W180986823 hasConcept C177713679 @default.
- W180986823 hasConcept C204787440 @default.
- W180986823 hasConcept C2775832370 @default.
- W180986823 hasConcept C2776235491 @default.
- W180986823 hasConcept C2776551883 @default.
- W180986823 hasConcept C2777562237 @default.
- W180986823 hasConcept C2777899217 @default.
- W180986823 hasConcept C2778164427 @default.
- W180986823 hasConcept C2778941218 @default.
- W180986823 hasConcept C2779161064 @default.
- W180986823 hasConcept C2779478474 @default.
- W180986823 hasConcept C2779929075 @default.
- W180986823 hasConcept C2780192828 @default.
- W180986823 hasConcept C2780435053 @default.
- W180986823 hasConcept C2780524745 @default.
- W180986823 hasConcept C2780542891 @default.
- W180986823 hasConcept C2780816001 @default.
- W180986823 hasConcept C61367390 @default.
- W180986823 hasConcept C71924100 @default.
- W180986823 hasConceptScore W180986823C121608353 @default.
- W180986823 hasConceptScore W180986823C126322002 @default.
- W180986823 hasConceptScore W180986823C126894567 @default.
- W180986823 hasConceptScore W180986823C142724271 @default.
- W180986823 hasConceptScore W180986823C177713679 @default.
- W180986823 hasConceptScore W180986823C204787440 @default.
- W180986823 hasConceptScore W180986823C2775832370 @default.
- W180986823 hasConceptScore W180986823C2776235491 @default.
- W180986823 hasConceptScore W180986823C2776551883 @default.
- W180986823 hasConceptScore W180986823C2777562237 @default.
- W180986823 hasConceptScore W180986823C2777899217 @default.
- W180986823 hasConceptScore W180986823C2778164427 @default.
- W180986823 hasConceptScore W180986823C2778941218 @default.
- W180986823 hasConceptScore W180986823C2779161064 @default.
- W180986823 hasConceptScore W180986823C2779478474 @default.
- W180986823 hasConceptScore W180986823C2779929075 @default.
- W180986823 hasConceptScore W180986823C2780192828 @default.
- W180986823 hasConceptScore W180986823C2780435053 @default.
- W180986823 hasConceptScore W180986823C2780524745 @default.
- W180986823 hasConceptScore W180986823C2780542891 @default.
- W180986823 hasConceptScore W180986823C2780816001 @default.
- W180986823 hasConceptScore W180986823C61367390 @default.
- W180986823 hasConceptScore W180986823C71924100 @default.
- W180986823 hasLocation W1809868231 @default.
- W180986823 hasOpenAccess W180986823 @default.
- W180986823 hasPrimaryLocation W1809868231 @default.
- W180986823 hasRelatedWork W180986823 @default.
- W180986823 hasRelatedWork W1997939870 @default.
- W180986823 hasRelatedWork W2034776085 @default.
- W180986823 hasRelatedWork W2053732828 @default.
- W180986823 hasRelatedWork W23586611 @default.
- W180986823 hasRelatedWork W2607154394 @default.
- W180986823 hasRelatedWork W2610354852 @default.
- W180986823 hasRelatedWork W3155477964 @default.
- W180986823 hasRelatedWork W3164901414 @default.
- W180986823 hasRelatedWork W3202716119 @default.
- W180986823 hasVolume "19 Suppl 1" @default.